You have full text access to this OnlineOpen article

Intraoperative floppy iris syndrome (IFIS): a practical approach to medical and surgical considerations in cataract extractions

  1. Allan Storr-Paulsen1,2,
  2. Jens Christian Nørregaard1,2,
  3. Kim Kamp Børme1,
  4. Allan Boye Larsen1,
  5. Jesper Thulesen1

Article first published online: 24 JUN 2009

DOI: 10.1111/j.1755-3768.2008.01442.x

Issue

Acta Ophthalmologica

Acta Ophthalmologica

Volume 87, Issue 7, pages 704–708, November 2009

Additional Information

How to Cite

Storr-Paulsen, A., Nørregaard, J. C., Børme, K. K., Larsen, A. B. and Thulesen, J. (2009), Intraoperative floppy iris syndrome (IFIS): a practical approach to medical and surgical considerations in cataract extractions. Acta Ophthalmologica, 87: 704–708. doi: 10.1111/j.1755-3768.2008.01442.x

Author Information

  1. 1

    Department of Ophthalmology, Frederiksberg University Hospital, Frederiksberg, Denmark

  2. 2

    Department of Neurology, Psychiatry and Sensory Sciences, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark

*Allan Storr-Paulsen MD Department of Ophthalmology Frederiksberg University Hospital DK-2000 Frederiksberg Denmark Tel: +45 38 16 36 46 Fax: +45 38 16 36 39 Email: allanstorr@dadlnet.dk

Publication History

  1. Issue published online: 20 OCT 2009
  2. Article first published online: 24 JUN 2009
  3. Received on June 17th, 2008. Accepted on August 14th, 2008.

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (148K)

Keywords:

  • benign prostatic hyperplasia;
  • cataract extraction;
  • intraoperative floppy iris syndrome (IFIS);
  • lower urinary tract symptoms;
  • phacoemulsification;
  • α-1 adrenergic receptor antagonists

Abstract.

Intraoperative floppy iris syndrome (IFIS) during cataract surgery is characterized by iris fluttering, iris prolapse towards the incisions, and a progressive pupillary constriction leading to high rates of complications. The syndrome has been reported following the treatment of benign prostatic hyperplasia with α-1a adrenergic receptor inhibitors, especially tamsulosin. The present paper describes the syndrome and discusses its pharmacological background. Several techniques to prevent and to deal with the syndrome are presented.

View Full Article (HTML) Get PDF (148K)